Research graph
References from Exploring the Patient Perspective of Gene Therapy for Sickle Cell Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Population Estimates of Sickle Cell Disease in the U.S
10.1016/j.amepre.2009.12.022 · 2010 · External reference
Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000‐2021: A Systematic Analysis From the Global Burden of Disease Study 2021
10.1016/s2352-3026(23)00118-7 · 2023 · External reference
Unresolved reference
2023 · External reference
Gene Therapy in Sickle Cell Disease: Attitudes and Informational Needs of Patients and Caregivers
10.1002/pbc.30319 · 2023 · External reference
Listening to Patients and Parents With Sickle Cell Disease: The Totality of Gene Therapy Risks May Outweigh the Perceived Benefits
10.1182/bloodadvances.2024012963 · 2024 · External reference
Preferences for Potential Benefits and Risks for Gene Therapy in the Treatment of Sickle Cell Disease
10.1182/bloodadvances.2023009680 · 2023 · External reference
Current and Future Treatments for Sickle Cell Disease: From Hematopoietic Stem Cell Transplantation to In Vivo Gene Therapy
10.1016/j.ymthe.2025.03.016 · 2025 · External reference
Mobilization Meets Antibody Conditioning: A Path Toward Safer Engraftment
10.1016/j.ymthe.2025.09.018 · 2025 · External reference
